HomeCUP • FRA
add
Chugai Pharmaceutical Co Ltd
Nakaraang pagsara
€49.48
Sakop ng araw
€49.00 - €49.27
Sakop ng taon
€33.02 - €56.26
Market cap
14.74T JPY
Average na Volume
42.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 346.30B | 14.64% |
Gastos sa pagpapatakbo | 89.74B | 6.36% |
Net na kita | 128.41B | 40.25% |
Net profit margin | 37.08 | 22.34% |
Kita sa bawat share | — | — |
EBITDA | 200.44B | 30.27% |
Aktuwal na % ng binabayarang buwis | 24.42% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 979.70B | -1.67% |
Kabuuang asset | 2.47T | 11.78% |
Kabuuang sagutin | 442.86B | 44.31% |
Kabuuang equity | 2.03T | — |
Natitirang share | 1.65B | — |
Presyo para makapag-book | 0.04 | — |
Return on assets | 18.16% | — |
Return on capital | 21.44% | — |
Cash Flow
Net change in cash
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 128.41B | 40.25% |
Cash mula sa mga operasyon | 129.11B | -15.28% |
Cash mula sa pag-invest | -161.72B | -856.78% |
Cash mula sa financing | -2.25B | -10.98% |
Net change in cash | -29.83B | -121.89% |
Malayang cash flow | 111.73B | -32.63% |
Tungkol
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
CEO
Itinatag
Mar 10, 1925
Website
Mga Empleyado
7,872
